会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Particles for NMR imaging
    • 核磁共振成像用颗粒
    • US5464696A
    • 1995-11-07
    • US096414
    • 1993-07-26
    • Herve TournierRoland HyacintheMichel Schneider
    • Herve TournierRoland HyacintheMichel Schneider
    • A61K9/127A61B5/055A61K20060101A61K49/00A61K49/18B23B5/16
    • A61K49/1806A61K49/1839Y10S977/838Y10S977/904Y10S977/905Y10S977/927Y10S977/96Y10T428/2991Y10T428/2998Y10T436/24
    • Magnetite particles suitable for injection into the blood stream of patients having enhanced resistance against agglomeration and uptake by the RES of the liver and spleen. The particles essentially consist of an iron oxide core and a phosphoric acid mono alkyl or alkenyl ester or glycerophospholipid/surfactant three dimensional shell surrounding the core. The core and the monoester or a micellar glycerophospholipid form an urchin-like structure which is further interlaced or intertwined with a non-ionic surfactant to produce a protective three dimensional shell which renders particles almost undetectable by the macrophages. Particles prepared according to the invention are kept in the blood circulation for long periods and represent excellent long lasting blood pool agents. Key components in the shell are (a) a polybasic mineral-organic species such as glycero phosphatidic acid in micellar form and (b) a block copolymer having successive hydrophilic and hydrophobic segments.
    • 适合于注射到患有肝脏和脾脏的RES的聚集和摄取的抗性的患者血液中的磁铁矿颗粒。 颗粒基本上由氧化铁芯和磷酸单烷基或链烯基酯或包含核心的甘油磷脂/表面活性剂三维壳组成。 核心和单酯或胶束甘油磷脂形成海胆样结构,其进一步与非离子表面活性剂交织或交织在一起,以产生保护性三维壳,其使颗粒几乎不被巨噬细胞检测到。 根据本发明制备的颗粒长时间保持在血液循环中并且代表优异的持久的血液池剂。 壳中的关键组分是(a)多元矿物有机物质,例如胶束形式的甘油磷脂酸,和(b)具有连续亲水和疏水链段的嵌段共聚物。
    • 9. 发明授权
    • Blood-pool imaging composition comprising micelles containing a
lipophilic chelating agent and a non-ionic surfactant
    • 包含含有亲脂性螯合剂和非离子表面活性剂的胶束的血池成像组合物
    • US5833948A
    • 1998-11-10
    • US663545
    • 1996-06-13
    • Herve TournierBernard LamyRoland Hyacinthe
    • Herve TournierBernard LamyRoland Hyacinthe
    • A61K49/00A61K49/18A61B5/055
    • A61K49/1806Y10S514/836Y10S514/937
    • The invention concerns NMR imaging contrast compositions comprising magnetically responsive species coupled to physiologically acceptable amphipatic organic substrate materials in the form of mixed micelles suspended or dispersed in a physiologically acceptable aqueous liquid carrier. The compositions are particularly useful for diagnostic investigations of the blood-pool. The invention also concerns the preparation of the mixed micelles, as well as of injectable compositions containing the mixed micelles as contrast agents for MRI purpose. Once injected, the mixed micelles of the compositions behave as imaging contrast enhancers, e.g. they will improve the quality and resolution of the electronically processed images obtained during MRI examinations of the circulation and/or circulation targeted organs. The compositions are formulated to protect the particles of the contrast agents from early removal by the reticulo-endothelial (RES) system of the liver and the spleen, so that they will stay in the circulation for a time sufficient to properly image the blood vessels and to be transported to selected organs. MRI imaging of the circulation and of targeted organs can strongly assist in diagnosing possible ailments in human and animal patients.
    • 本发明涉及包含悬浮或分散在生理上可接受的水性液体载体中的混合胶束形式的生理上可接受的两亲性有机底物材料的磁响应物质的NMR成像对比剂组合物。 该组合物特别适用于血液池的诊断研究。 本发明还涉及混合胶束的制备,以及含有混合胶束作为MRI目的的造影剂的可注射组合物。 一旦注射,组合物的混合胶束表现为成像对比增强剂,例如, 它们将提高在循环和/或循环目标器官的MRI检查期间获得的电子处理图像的质量和分辨率。 配制组合物以保护造影剂的颗粒免于肝脏和脾脏的网状内皮(RES)系统的早期去除,使得它们将停留在循环中足以适当地使血管成像的时间, 被运送到选定的器官。 循环和目标器官的MRI成像可以有力地帮助诊断人类和动物患者的可能的疾病。